Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Biotech
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
AI firm Xaira powers up C-suite with pharma vet. Genesis shakes up leadership to advance AI platform. Restructuring Carisma cuts execs loose.
Darren Incorvaia
,
Zoey Becker
Dec 13, 2024 8:30am
Merck KGaA tumor trial hits goal, teeing up Daiichi, Ono rivalry
Nov 12, 2024 4:46am
Merck KGaA drops xevinapant with ph. 3 trial headed for failure
Jun 25, 2024 8:50am
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
Jun 4, 2024 9:45am
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
Apr 18, 2024 4:05pm
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
